UK markets closed
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • FTSE 250

    20,910.37
    -287.75 (-1.36%)
     
  • AIM

    1,183.25
    -8.61 (-0.72%)
     
  • GBP/EUR

    1.1532
    +0.0034 (+0.30%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.65%)
     
  • BTC-GBP

    33,894.59
    +117.73 (+0.35%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • DOW

    30,932.37
    -469.64 (-1.50%)
     
  • CRUDE OIL

    61.66
    -1.87 (-2.94%)
     
  • GOLD FUTURES

    1,733.00
    -42.40 (-2.39%)
     
  • NIKKEI 225

    28,966.01
    -1,202.26 (-3.99%)
     
  • HANG SENG

    28,980.21
    -1,093.96 (-3.64%)
     
  • DAX

    13,786.29
    -93.04 (-0.67%)
     
  • CAC 40

    5,703.22
    -80.67 (-1.39%)
     

US Cannabidiol (CBD) Market (2020 to 2024) - Size & Forecasts with Impact Analysis of COVID-19 - ResearchAndMarkets.com

·4-min read

The "The US Cannabidiol (CBD) Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering.

The report provides an in-depth analysis of the CBD market in the US including detailed description of market sizing and growth. The report provides an analysis of the US CBD market followed by US Hemp-Derived CBD market and its various segments.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall CBD market in the US has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Company Coverage

  • Charlotte's Web Holdings, Inc

  • CV Sciences, Inc.

  • Reliva CBD Wellness

  • Elixinol Global Limited (Elixinol USA)

Cannabidiol (CBD) has been segmented into hemp-derived, marijuana-derived and pharmaceutical. Hemp-derived CBD has been further segmented on the basis of product and distribution channel. Based on product, hemp-derived CBD has been segregated into tinctures, topicals, capsules, vape oil/ cartridges, gummies, other edibles, pre-roll/ flower and syrups and dabs. On the basis of distribution channel, hemp-derived CBD has been divided into natural food stores, online, smoke shops, dispensaries, medical companies and others.

The US Cannabidiol (CBD) market is expected to rise significantly during the period 2020-2024. The market is expected to be driven by various growth-enhancing factors such as aging population, the growing use of CBD among millennials, increasing prevalence of arthritis, removal of hemp from the Controlled Substance Act, etc. However, the market is not free from challenges that are hindering its growth. Some of the major challenges faced by the market are lack of regulatory clarity and ineffective and unregulated products.

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Cannabidiol (CBD): An Overview

2.1.1 Impact of CBD

2.1.2 CBD Legality in the US

2.1.3 CBD Products

2.1.4 Side Effects of CBD

2.2 Cannabidiol (CBD) Segmentation: An Overview

2.3 Hemp-derived Cannabidiol (CBD) Segmentation: An Overview

3. The US Market Analysis

3.1 The US CBD Market: An Analysis

3.2 The US Hemp-Derived CBD Market: Analysis

3.2.1 The US Hemp-derived CBD Market by Value

3.2.2 The US Hemp-derived CBD Market by Product (Tinctures, Topicals, Vape Oil and Cartridges, Capsules, Pets, Gummies, Beauty and Skincare, Pre-Roll and Others)

3.2.3 The US Hemp-derived Tinctures CBD Market by Value

3.2.4 The US Hemp-derived Topicals CBD Market by Value

3.2.5 The US Hemp-derived Vape Oil and Cartridges CBD Market by Value

3.2.6 The US Hemp-derived Capsules CBD Market by Value

3.2.7 The US Hemp-derived Pets CBD Market by Value

3.2.8 The US Hemp-derived Gummies CBD Market by Value

3.2.9 The US Hemp-derived Beauty and Skincare CBD Market by Value

3.2.10 The US Hemp-derived Pre-Roll CBD Market by Value

4. Impact of COVID-19

4.1 Impact on the US CBD Market

4.1.1 Impact on Operations of CBD Companies

4.1.2 Challenges

4.1.3 Opportunities

4.1.4 Contraction in Prices

4.1.5 Pandemic encouraging Innovation

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Aging Population

5.1.2 Rising Disposable Income

5.1.3 Growing Use of CBD among Millennials

5.1.4 Increasing Prevalence of Arthritis

5.1.5 Removal of Hemp from Controlled Substance Act

5.2 Challenges

5.2.1 Lack of Regulatory Clarity

5.2.2 Ineffective and Unregulated Products

5.3 Market Trends

5.3.1 Use of Blockchain Technology

5.3.2 Rapidly Growing Online Retail

6. Competitive Landscape

6.1 The US CBD Market Players: Primary Competitors Analysis

6.2 The US CBD Players: Financial Comparison

6.3 The US CBD Market Players by Instagram Followers

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/oy4w7y

View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005262/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900